今海医疗科技(02225.HK) 预计,截至2024年12月31日止年度税后亏损约1,810万新加坡元,而2023财年则录得税后亏损约410万坡元。亏损净额状况增加主要由于行政费用增加约1,590万新加坡元,主要由于集团于2024财年向若干员工授予购股权产生约1,330万新加坡元的以股权结算的股份支付款项开支。(ha/a)(港股报价延迟最少十五分钟。)
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2024/11/01 | 特别业绩 | 股份拆细:1股拆4股 |
2024/08/30 | 中期业绩 | 无派息 |
2024/03/28 | 末期业绩 | 无派息 |
2023/08/30 | 中期业绩 | 无派息 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.